EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Loss of FTSJ3 promotes R-loop-associated DNA damage and facilitates chemosensitivity in lung cancer cells

Hongchengcheng Chen, Guihui Yu, Haodong Lin, Xiao Albert Zhou, Jiansong Liu, Haoyun Liu, Yefei Luo, Kaiqi Cheng, Zuchao Mao, Yujie Ma, Jun Wang, Kezhong Chen und 2 weitere

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Hongchengcheng Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China; Thoracic Oncology Institute, Peking University People's …. Hauptthemen laut MEDLINE: Lung Neoplasms, DNA Damage, Drug Resistance, Neoplasm, Adenocarcinoma of Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

R-loop accumulation has emerged as a critical factor that induces DNA damage and compromises genomic integrity. However, the regulatory mechanisms governing the R-loop-induced DNA damage remain unclear. Here, FTSJ3 was determined to be a pivotal regulator of R-loop homeostasis and genomic stability. We demonstrated that FTSJ3 was specifically recruited to R-loop structures, where it prevented DNA damage by suppressing excessive R-loop formation. FTSJ3 expression was significantly upregulated in multiple cancer types, and its elevated expression levels correlated with unfavorable survival in patients with lung adenocarcinoma (LUAD). FTSJ3 depletion increased R-loop-dependent DNA damage. Inhibiting FTSJ3 expression sensitized lung cancer cells to cisplatin both in vitro and in vivo. FTSJ3 could be a genome guardian that limits R-loop-associated damage, suggesting its potential role as a cancer intervention therapeutic target and a predictive biomarker for chemotherapy responsiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsDNA DamageDrug Resistance, NeoplasmAdenocarcinoma of LungHumansCisplatinAnimalsCell Line, TumorXenograft Model Antitumor AssaysMiceGene Expression Regulation, NeoplasticAntineoplastic AgentsA549 CellsMice, Nude

Stichwörter der Autor:innen

ChemosensitivityDNA damageFTSJ3R-loop

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Peking University People's Hospital, Beijing, 100044, China; Thoracic Oncology Institute, Peking University People's Hospital, Beijing, 100044, China; Research Unit of Intelligence Diagno…
  • Department of Radiation Medicine, School of Basic Medical Sciences, Peking University International Cancer Institute, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing, 10…

Zitieren

APA

Chen, H., Yu, G., Lin, H., Zhou, X. A., Liu, J., Liu, H., Luo, Y., Cheng, K., Mao, Z., Ma, Y., Wang, J., Chen, K., Wang, J., & Li, Y. (2025). Loss of FTSJ3 promotes R-loop-associated DNA damage and facilitates chemosensitivity in lung cancer cells. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217877

Vancouver

Chen H, Yu G, Lin H, Zhou XA, Liu J, Liu H, et al. Loss of FTSJ3 promotes R-loop-associated DNA damage and facilitates chemosensitivity in lung cancer cells. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217877

BibTeX
@article{Chen2025,
  author = {Chen, Hongchengcheng and Yu, Guihui and Lin, Haodong and Zhou, Xiao Albert and Liu, Jiansong and Liu, Haoyun and Luo, Yefei and Cheng, Kaiqi and Mao, Zuchao and Ma, Yujie and Wang, Jun and Chen, Kezhong and Wang, Jiadong and Li, Yun},
  title = {Loss of FTSJ3 promotes R-loop-associated DNA damage and facilitates chemosensitivity in lung cancer cells},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217877}
}
Kostenlos starten →